Consensus TaiMed Biologics Inc.

Equities

4147

TW0004147004

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-06-20 EDT			5-day change	1st Jan Change
88.9 ^TWD	-1.11%		-2.31%	+8.41%

05-20	Orient Europharma Co., Ltd. Signs an Exclusive Sales and Marketing Agreement for the New AIDS Drug Trogarzo in Taiwan with Taimed Biologics	CI
05-20	TaiMed Biologics Inc. and Orient EuroPharma Company Limited Signs Trogarzo Commercial License Agreement in Taiwan	CI

Evolution of the average Target Price on TaiMed Biologics Inc.

Price target over the last 5 years

History of analyst recommendation changes

2839906f11e3ccc8d3792c73b.eOJY9-9tYROOLwjx-ZUxSFuphkS6J4XiaQFDehRejqs.MYw6pIo_KH__FnKJrM9VAD3b8R34abCtBWIFHXMmzOU8jymzvS4FJelNew~cbdd45ae9245d0eb14768e8ea704400c